BiomX Inc. (PHGE)
NYSEAMERICAN: PHGE · Real-Time Price · USD
4.620
-0.090 (-1.91%)
Mar 27, 2026, 4:00 PM EDT - Market closed
BiomX Employees
BiomX had 20 employees as of December 31, 2025. The number of employees decreased by 37 or -64.91% compared to the previous year.
Employees
20
Change (1Y)
-37
Growth (1Y)
-64.91%
Revenue / Employee
n/a
Profits / Employee
-$1,809,950
Market Cap
7.36M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 20 | -37 | -64.91% | 20 | 0 |
| Dec 31, 2024 | 57 | -14 | -19.72% | 52 | 5 |
| Dec 31, 2023 | 71 | 6 | 9.23% | 58 | 13 |
| Dec 31, 2022 | 65 | -54 | -45.38% | 54 | 11 |
| Dec 31, 2021 | 119 | 13 | 12.26% | 103 | 16 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Employee RankingsPHGE News
- 10 hours ago - BiomX Inc. Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency - GlobeNewsWire
- 1 day ago - BiomX Launches Security Subsidiary in Israel and Will Initially Invest Over $3 million In Its Operations - GlobeNewsWire
- 8 days ago - BiomX CEO Issues Letter to Stockholders - PRNewsWire
- 18 days ago - BiomX Names Michael Oster as Chief Executive Officer, David Rokach Chief Financial Officer to Support Next Phase of Growth - PRNewsWire
- 2 months ago - BiomX Issues Statement Regarding Recent Common Stock Trading Activity - GlobeNewsWire
- 3 months ago - BiomX Announces $3.0 Million Private Placement - GlobeNewsWire
- 4 months ago - BiomX Awaits FDA Clearance To Restart Cystic Fibrosis Trial After Nebulizer Device Review - Benzinga
- 4 months ago - BiomX Provides Update on BX004 Phase 2b Trial in Cystic Fibrosis - GlobeNewsWire